Popular weight loss medications like semaglutide may cause more muscle loss than expected, raising concerns about mobility and fall risks for older patients.
Most Recent Articles
Gut Microbiome Signatures and Recurrence-Free Survival in High-Risk Melanoma
New research reveals that a patient's gut microbiome can predict melanoma recurrence with up to 94% accuracy, providing a powerful tool for personalizing immunotherapy after cancer surgery.
Modeling Serotonergic Signaling Deficits in Alzheimer’s Hindbrain Organoids
New research using patient-derived brain organoids reveals how molecular differences between individuals determine whether Alzheimer’s patients will respond to common antidepressant treatments.
Deficits in Thoroughness and Organization: Evaluating Ambient AI Scribes
New research shows that clinical notes produced by AI scribes are significantly lower in quality compared to human-written documentation, highlighting major gaps in thoroughness and clinical utility.
Syphilis as an Independent Risk Factor for Aortic Aneurysm and Stroke
New research reveals that late-stage syphilis can double the risk of aortic aneurysms and significantly increase stroke and heart attack rates, even after the infection is cured.